テロメア標的化キメラは,テロメア重複結合因子タンパク質の標的化破壊を可能にします.
PubMedで要約を見る
まとめ
この要約は機械生成です。TeloTACと呼ばれる新しいヌクレオチドベースのPROTACは,テロメア重複結合因子 (TRF1/2) を分解する. これはテロメアを短くし 癌細胞の増殖を抑制し 有望な新しい癌治療法です
科学分野
- 分子生物学
- 腫瘍学
- 薬物の発見
背景
- テロメアの縮小は 正常な老化細胞の特徴です
- がん細胞はしばしばテロメラーゼを再活性化してテロメアの長さを維持し,制御不能な増殖を可能にします.
- テロメアと関連するタンパク質は,抗がん治療の重要な標的です.
研究 の 目的
- 癌治療のための新しい核酸ベースのタンパク質分解標的キメラ (PROTAC) を開発する.
- テロメア重複結合因子1/2 (TRF1/2) を標的とし,テロメア長さの主要な調節体を劣化させる.
- がん細胞系におけるこれらのTeloTACの有効性を評価する.
主な方法
- 核酸ベースのPROTAC (TeloTAC) の設計と合成
- VHLとプロテアソームに依存した方法でTRF1/ 2の分解を評価する.
- テロメア長さの動態と癌細胞の増殖抑制の評価
主要な成果
- TeloTACsは,がん細胞におけるTRF1/ 2を効果的に分解した.
- TRF1/ 2の劣化により,テロメアの短縮が顕著になった.
- TeloTAC治療の後に癌細胞増殖の抑制が観察されました.
- TRF1/2を過剰発現する癌細胞の選択的殺戮が実証された.
結論
- テロTACはテロメアをターゲットにするための新しいヌクレオチドベースのアプローチを表しています.
- この戦略は テロメアを短くし 腫瘍細胞の成長を抑制します
- TeloTACsは,広範囲の抗がん治療薬としての可能性を示しています.
関連する概念動画
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...

